Jayasutha Jayram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jayasutha Jayram has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Christian Gnanaraj Johnson
National Institute of Siddha, Chennai, TN, India
1 shared publication- Gaurav Tiwari
PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kalpi Road, Bhauti, Kanpur-208020, India
1 shared publication K. Thejomoorthy
1 shared publication- K.P. Jaiganesh1 shared publication
- Mahesh Kumar Posa
Department of Pharmacology, School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India; Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Barasat, Kolkata, West Bengal, India
1 shared publication - Mangathayaru Kalachaveedu
Faculty of Pharmacy, Sri Ramachandra University, Chennai, India
1 shared publication
Latest Publications
- 17 April 2026
- Published by Elsevier
- p. 179-201
Nanostructures in embryo viability and implantation
- 1 March 2026
- Published by SAGE Publications in Tumori Journal
- Vol. 112 (2) , 118-123
Quality of life and sexual function after breast conservation surgery and mastectomy without reconstruction in South Indian patients
Background: Breast cancer is a leading malignancy among women worldwide, significantly affecting physical, psychological, and sexual well-being. Surgical options such as breast conservation surgery (BCS) and mastectomy have distinct implications on patients' quality of life. This study aimed to compare health-related quality of life (HRQoL) and sexual functioning in breast cancer patients undergoing BCS or mastectomy. Methods: A prospective observational study was conducted over a 10-month period at a tertiary care hospital. Sixty-five breast cancer patients aged 20–50 years, who underwent either BCS (n=33) or mastectomy (n=32), were enrolled. Data were collected on baseline characteristics and HRQoL and sexual functioning were assessed using the EORTC QLQ-BR42 and Female Sexual Function Index (FSFI) questionnaires. Results: BCS patients reported significantly better scores in FSFI domains such as desire, lubrication, orgasm, and satisfaction (p<0.05), with a higher final FSFI score (5.53 ± 1.78) compared to mastectomy patients (3.93 ± 1.06). On the BR42 scale, BCS patients showed better body image and satisfaction scores (p<0.05). No significant differences were observed in systemic side effects, future health worries, and sexuality domains between the groups. Conclusion: Breast conservation surgery patients had better sexual function and quality of life compared to mastectomy patients. These findings underscore the importance of incorporating quality-of-life outcomes in surgical decision-making and preoperative counseling for breast cancer patients.
- 1 March 2026
- Published by SAGE Publications in Tumori Journal
- Vol. 112 (2) , 118-123
Quality of life and sexual function after breast conservation surgery and mastectomy without reconstruction in South Indian patients
Background: Breast cancer is a leading malignancy among women worldwide, significantly affecting physical, psychological, and sexual well-being. Surgical options such as breast conservation surgery (BCS) and mastectomy have distinct implications on patients' quality of life. This study aimed to compare health-related quality of life (HRQoL) and sexual functioning in breast cancer patients undergoing BCS or mastectomy. Methods: A prospective observational study was conducted over a 10-month period at a tertiary care hospital. Sixty-five breast cancer patients aged 20–50 years, who underwent either BCS (n=33) or mastectomy (n=32), were enrolled. Data were collected on baseline characteristics and HRQoL and sexual functioning were assessed using the EORTC QLQ-BR42 and Female Sexual Function Index (FSFI) questionnaires. Results: BCS patients reported significantly better scores in FSFI domains such as desire, lubrication, orgasm, and satisfaction (p<0.05), with a higher final FSFI score (5.53 ± 1.78) compared to mastectomy patients (3.93 ± 1.06). On the BR42 scale, BCS patients showed better body image and satisfaction scores (p<0.05). No significant differences were observed in systemic side effects, future health worries, and sexuality domains between the groups. Conclusion: Breast conservation surgery patients had better sexual function and quality of life compared to mastectomy patients. These findings underscore the importance of incorporating quality-of-life outcomes in surgical decision-making and preoperative counseling for breast cancer patients.
- 27 October 2021
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 23 (2) , 291-305
Challenges and Prospects of Development of Herbal Biomaterial Based Ethical Wound Care Products—A Scoping Review
Total wound care is an unmet therapeutic need considering the morbidity and mortality associated with the rising prevalence of nonhealing/chronic wounds. Current wound management fails to address all aspects/types of wounds despite the availability of scores of traditional and modern, investigational products. Traditional medicine drugs of wound healing repute validated to target multiple biological pathways and key events in the mammalian wound healing cascade, reportedly affecting wound healing phases. Advances in the development of biocomposite matrices and their analytical characterization warrant a relook at consolidating time-tested wound healing properties of herbal bioactives for prospective development as ethical wound care products. Aside from the bottlenecks of their multiconstituent profiling and clinical trial data generation, regulatory hurdles also cloister any systematic attempts at their re-engineering into clinical deliverables. In the context of national policy changes to bring in totally indigenous solutions, countries with a huge knowledge/material resource on wound healing bioactives need to essentially facilitate the same.
- 27 October 2021
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 23 (2) , 291-305
Challenges and Prospects of Development of Herbal Biomaterial Based Ethical Wound Care Products—A Scoping Review
Total wound care is an unmet therapeutic need considering the morbidity and mortality associated with the rising prevalence of nonhealing/chronic wounds. Current wound management fails to address all aspects/types of wounds despite the availability of scores of traditional and modern, investigational products. Traditional medicine drugs of wound healing repute validated to target multiple biological pathways and key events in the mammalian wound healing cascade, reportedly affecting wound healing phases. Advances in the development of biocomposite matrices and their analytical characterization warrant a relook at consolidating time-tested wound healing properties of herbal bioactives for prospective development as ethical wound care products. Aside from the bottlenecks of their multiconstituent profiling and clinical trial data generation, regulatory hurdles also cloister any systematic attempts at their re-engineering into clinical deliverables. In the context of national policy changes to bring in totally indigenous solutions, countries with a huge knowledge/material resource on wound healing bioactives need to essentially facilitate the same.